Skip to main content
Pearson+ LogoPearson+ Logo
Ch. 24 - Cancer Genetics
Klug - Concepts of Genetics  12th Edition
Klug12th EditionConcepts of Genetics ISBN: 9780135564776Not the one you use?Change textbook
Chapter 24, Problem 25a

Mutations in tumor-suppressor genes are associated with many types of cancers. In addition, epigenetic changes (such as DNA methylation) of tumor-suppressor genes are also associated with tumorigenesis [Otani et al. (2013).
Expert Rev Mol Diagn 13:445-455].
How might hypermethylation of the TP53 gene promoter influence tumorigenesis?

Verified step by step guidance
1
Understand the role of the TP53 gene: TP53 is a tumor-suppressor gene that encodes the p53 protein, which plays a critical role in regulating cell cycle, DNA repair, and apoptosis. Its proper function is essential for preventing uncontrolled cell growth and tumor formation.
Learn about DNA methylation: DNA methylation is an epigenetic modification where methyl groups are added to cytosine bases in CpG islands, often found in gene promoters. This modification can influence gene expression by altering the accessibility of transcription factors and RNA polymerase to the DNA.
Analyze the effect of hypermethylation: Hypermethylation of the TP53 gene promoter can lead to transcriptional silencing of the gene. This means that the production of the p53 protein may be reduced or completely inhibited, impairing its tumor-suppressing functions.
Connect hypermethylation to tumorigenesis: Without functional p53 protein, cells may fail to undergo apoptosis or repair DNA damage, leading to the accumulation of mutations and uncontrolled cell division. This increases the risk of tumor formation and progression.
Summarize the impact: Hypermethylation of the TP53 gene promoter can contribute to tumorigenesis by silencing a key tumor-suppressor gene, thereby disrupting cellular mechanisms that prevent cancer development.

Verified video answer for a similar problem:

This video solution was recommended by our tutors as helpful for the problem above.
Video duration:
2m
Was this helpful?

Key Concepts

Here are the essential concepts you must grasp in order to answer the question correctly.

Tumor-Suppressor Genes

Tumor-suppressor genes are critical components of the cellular machinery that regulate cell growth and division. They function to prevent uncontrolled cell proliferation, and mutations in these genes can lead to cancer. The TP53 gene, often referred to as the 'guardian of the genome,' plays a vital role in maintaining genomic stability and initiating apoptosis in response to DNA damage.
Recommended video:
Guided course
09:09
Mapping Genes

DNA Methylation

DNA methylation is an epigenetic modification involving the addition of a methyl group to the DNA molecule, typically at cytosine bases. This process can regulate gene expression without altering the underlying DNA sequence. Hypermethylation of promoter regions, such as that of the TP53 gene, can silence gene expression, leading to the loss of tumor-suppressive functions and contributing to tumorigenesis.
Recommended video:
Guided course
01:45
DNA Proofreading

Tumorigenesis

Tumorigenesis is the process by which normal cells transform into cancerous cells, involving a series of genetic and epigenetic changes. This process can be driven by mutations in oncogenes and tumor-suppressor genes, as well as by epigenetic alterations like DNA methylation. Understanding how these changes contribute to tumorigenesis is crucial for developing targeted cancer therapies.
Recommended video:
Guided course
09:46
Cancer Characteristics
Related Practice
Textbook Question

Genetic tests that detect mutations in the BRCA1 and BRCA2 tumor-suppressor genes are widely available. These tests reveal a number of mutations in these genes—mutations that have been linked to familial breast cancer. Assume that a young woman in a suspected breast cancer family takes the BRCA1 and BRCA2 genetic tests and receives negative results. That is, she does not test positive for the mutant alleles of BRCA1 or BRCA2. Can she consider herself free of risk for breast cancer?

1082
views
Textbook Question

Explain the apparent paradox that both hypermethylation and hypomethylation of DNA are often found in the same cancer cell.

817
views
Textbook Question

As part of a cancer research project, you have discovered a gene that is mutated in many metastatic tumors. After determining the DNA sequence of this gene, you compare the sequence with those of other genes in the human genome sequence database. Your gene appears to code for an amino acid sequence that resembles sequences found in some serine proteases. Conjecture how your new gene might contribute to the development of highly invasive cancers.

557
views
Textbook Question

Mutations in tumor-suppressor genes are associated with many types of cancers. In addition, epigenetic changes (such as DNA methylation) of tumor-suppressor genes are also associated with tumorigenesis [Otani et al. (2013). Expert Rev Mol Diagn 13:445 455].

Knowing that tumors release free DNA into certain surrounding body fluids through necrosis and apoptosis, Kloten et al. [(2013). Breast Cancer Res. 15(1):R4] outlines an experimental protocol for using human blood as a biomarker for cancer and as a method for monitoring the progression of cancer in an individual.

466
views
Textbook Question

A study by Bose and colleagues (1998). Blood 92:3362-3367] and a previous study by Biernaux and others (1996). Bone Marrow Transplant 17:(Suppl. 3) S45–S47] showed that BCR-ABL fusion gene transcripts can be detected in 25 to 30 percent of healthy adults who do not develop chronic myelogenous leukemia (CML). Explain how these individuals can carry a fusion gene that is transcriptionally active and yet does not develop CML.

499
views
Textbook Question

Those who inherit a mutant allele of the RB1 tumor-suppressor gene are at risk for developing a bone cancer called osteosarcoma. You suspect that in these cases, osteosarcoma requires a mutation in the second RB1 allele, and you have cultured some osteosarcoma cells and obtained a cDNA clone of a normal human RB1 gene. A colleague sends you a research paper revealing that a strain of cancer-prone mice develops malignant tumors when injected with osteosarcoma cells, and you obtain these mice. Using these three resources, what experiments would you perform to determine:

(a) Whether osteosarcoma cells carry two RB1 mutations

(b) Whether osteosarcoma cells produce any pRB protein

(c) If the addition of a normal RB1 gene will change the cancer-causing potential of osteosarcoma cells?

447
views